Amarin Corp Plc (AMRN)

[Biobillionair]

"The transaction is expected to close by the third quarter of 2013 subject to regulatory approvals"

Why this is AZN not knowing how to negotiate an Amarin deal:

The NDA will be denied because of Lovaza's RDL & incomplete Patent information for a 505b2 or 505b1. Great that AZN was smart enough to wait for the application to get denied, but 3rd quarter is only within the 74 day communication period and NOT approval. They never intended to buy Omethera, only to use the press releases in negioations.

AZN hire me to negotiate a buyout, I'll charge you a $5 million flat fee (plus negotiated bonus) and cash out my shares at 5 year high.

Williams